Insider · CIK 0000901014

GIN JERRY B

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0000901014

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-09-06	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,100
2024-03-04	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2022-08-18	VTGNVistagen Therapeutics, Inc.P Purchase	Director	PPurchase	+100K sh	$0.18	+$17.9K	100,000
2022-08-18	VTGNVistagen Therapeutics, Inc.P Purchase	Director	PPurchase	+100K sh	$0.18	+$17.9K	100,000
2022-03-01	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+100K sh	—	—	100,000
2020-12-30	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2020-04-23	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2019-10-21	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2019-05-23	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2018-08-05	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2018-02-02	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+100K sh	—	—	100,000
2017-09-19	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2017-09-19	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2017-09-15	VTGNVistagen Therapeutics, Inc. · WarrantD Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2017-09-15	VTGNVistagen Therapeutics, Inc. · WarrantD Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2017-09-15	VTGNVistagen Therapeutics, Inc. · WarrantA Award	Director	AAward	+25K sh	—	—	25,000
2017-09-15	VTGNVistagen Therapeutics, Inc. · WarrantA Award	Director	AAward	+25K sh	—	—	25,000
2017-09-15	VTGNVistagen Therapeutics, Inc. · WarrantA Award	Director	AAward	+25K sh	—	—	25,000
2017-09-15	VTGNVistagen Therapeutics, Inc. · WarrantsA Award	Director	AAward	+25K sh	—	—	25,000
2017-05-31	VTGNVistagen Therapeutics, Inc.P Purchase	Director	PPurchase	+50K sh	—	—	50,000
2017-05-31	VTGNVistagen Therapeutics, Inc.P Purchase	Director	PPurchase	+50K sh	—	—	100,000
2017-05-31	VTGNVistagen Therapeutics, Inc. · WarrantP Purchase	Director	PPurchase	+25K sh	—	—	25,000
2017-05-31	VTGNVistagen Therapeutics, Inc. · WarrantP Purchase	Director	PPurchase	+25K sh	—	—	50,000
2017-04-26	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2016-11-09	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2016-06-19	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2016-03-30	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Sep 104
GIN JERRY B0001415889-24-023148
SEC(opens sec.gov)
Mar 64
GIN JERRY B0001415889-24-007098
SEC(opens sec.gov)
Aug 224
GIN JERRY B0001415889-22-008937
SEC(opens sec.gov)
Mar 34
GIN JERRY B0001415889-22-002292
SEC(opens sec.gov)
Jan 44
GIN JERRY B0001415889-21-000005
SEC(opens sec.gov)
Apr 274
GIN JERRY B0001415889-20-001061
SEC(opens sec.gov)
Oct 224
GIN JERRY B0001415889-19-001208
SEC(opens sec.gov)
May 284
GIN JERRY B0001415889-19-000595
SEC(opens sec.gov)
Aug 314
GIN JERRY B0001415889-18-001318
SEC(opens sec.gov)
Aug 64
GIN JERRY B0001415889-18-001230
SEC(opens sec.gov)
Feb 54
GIN JERRY B0001415889-18-000183
SEC(opens sec.gov)
Oct 64/A
GIN JERRY B0001415889-17-001635
SEC(opens sec.gov)

Companies

Vistagen Therapeutics, Inc.DirectorVTGN

Address

C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE

SOUTH SAN FRANCISCO, CA, 94080